| Literature DB >> 23577095 |
Wei Shen1, Yongming Yang, Minbin Yu, Jun Li, Tao Wei, Xun Li, Juanjuan Li, Xiaodan Su, Hua Zhong, Yuansheng Yuan.
Abstract
PURPOSE: To investigate the prevalence and visual acuity (VA) outcomes of cataract surgery in adults of the Bai Nationality populations in rural China.Entities:
Mesh:
Year: 2013 PMID: 23577095 PMCID: PMC3618447 DOI: 10.1371/journal.pone.0060236
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Cataract Surgery by Age, Gender, and Education.
| Variables | Examined | Post-operative Persons | Adjusted OR | P Value | |
| No. (%) | No. | % Prevalence(95% CI) | (95% CI) | ||
|
| |||||
| 50–59 | 715(33.5) | 7 | 1.0 (0.3–1.7) | Reference | |
| 60–69 | 775(36.3) | 21 | 2.7 (1.6–3.9) | 2.96(1.24–7.05) | 0.014 |
| 70–79 | 525(24.6) | 50 | 9.5 (7.0–12.0) | 10.97(4.76–25.30) | 0.000 |
| 80+ | 118(5.5) | 21 | 17.8 (10.0–24.7) | 22.36(8.93–55.99) | 0.000 |
|
| |||||
| Male | 769(36.1) | 35 | 4.6 (3.1–6.0) | Reference | |
| Female | 1364(63.9) | 64 | 4.7 (3.6–5.8) | 1.06(0.65–1.74) | 0.817 |
|
| |||||
| >6 | 506(23.7) | 17 | 3.4 (1.8–4.9) | Reference | |
| 1–6 | 868(40.7) | 29 | 3.3 (2.2–4.5) | 0.68(0.36–1.28) | 0.234 |
| 0 | 759(35.6) | 53 | 7.0 (5.2–8.8) | 0.86(0.44–1.69) | 0.661 |
|
| 2133(100) | 99 | 4.6 (3.8–5.5) | ||
OR: odds ratios; CI: Confidence Interval.
Post-operative and Unopreted Persons with Cataract-Related Severe Visual Impairment or Blindness (<20/200) by Age, Gender, and Education.
| Post-operative Persons | Unopreted Persons | |||||||||
| Variables | Examined | All Operated | Presumed Severe Visual Impairment or Blindness | Cataract Severe Visual Impairment or Blindness | Cataract Social Burdon | Surgical Coverage (%) | ||||
| No. | No. | Prevalence | No. | Prevalence | No. | Prevalence | No | Prevalence | ||
|
| . | |||||||||
| 50–59 | 715 | 7 | 1.0 | 4 | 0.6 | 3 | 0.4 | 7 | 1.0 | 57.1 |
| 60–69 | 775 | 21 | 2.7 | 13 | 1.7 | 9 | 1.2 | 22 | 2.8 | 59.1 |
| 70–79 | 525 | 50 | 9.5 | 41 | 7.8 | 38 | 7.2 | 79 | 15.0 | 51.9 |
| 80+ | 118 | 21 | 17.8 | 18 | 15.3 | 18 | 15.3 | 36 | 30.5 | 50.0 |
|
| ||||||||||
| Male | 769 | 35 | 4.6 | 27 | 3.5 | 25 | 3.3 | 52 | 6.8 | 51.9 |
| Female | 1364 | 64 | 4.7 | 49 | 3.6 | 43 | 3.2 | 92 | 6.7 | 53.3 |
|
| ||||||||||
| >6 | 506 | 17 | 3.4 | 10 | 2.0 | 5 | 1.0 | 15 | 3.0 | 66.7 |
| 1–6 | 868 | 29 | 3.3 | 20 | 2.3 | 22 | 2.5 | 42 | 4.8 | 47.6 |
| 0 | 759 | 53 | 7.0 | 46 | 6.1 | 41 | 5.4 | 87 | 11.4 | 52.9 |
|
| 2133 | 99 | 4.6 | 76 | 3.6 | 68 | 3.2 | 144 | 6.8 | 52.8 |
Visual acuity <20/200.
Prevalence per 100 examined participants.
Includes all bilaterally operated persons and unilaterally operated persons with a severely visually impaired or blind fellow eye.
Association of Age, Gender, and Education with Cataract-Related Severe Visual Impairment or Blindness (<20/200) by Multiple Logistic Regression Analysis.
| Variables | Post-operative Presumed Severely Impaired or Blind | Unoperated Cataract Severely Impaired or Blind | Cataract Social Burdon | Cataract Surgical Coverage | ||||
| Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | |
|
| ||||||||
| 50–59 | Reference | Reference | Reference | Reference | ||||
| 60–69 | 3.01 (0.97–9.34) | 0.057 | 2.51 (0.67–9.37) | 0.171 | 2.80 (1.18–6.62) | 0.019 | 1.18 (0.21–6.77) | 0.855 |
| 70–79 | 13.19 (4.53–38.37) | 0.000 | 14.54 (4.33–48.80) | 0.000 | 14.75 (6.59–33.00) | 0.000 | 0.77 (0.15–3.97) | 0.753 |
| 80+ | 27.63 (8.86–86.16) | 0.000 | 33.28 (9.36–118.40) | 0.000 | 36.16 (15.25–85.73) | 0.000 | 0.72 (0.13–4.02) | 0.704 |
|
| ||||||||
| Male | Reference | Reference | Reference | Reference | ||||
| Female | 0.88 (0.50–1.55) | 0.657 | 0.81 (0.44–1.46) | 0.477 | 0.83 (0.54–1.28) | 0.403 | 1.20 (0.52–2.76)) | 0.677 |
|
| ||||||||
| >6 | Reference | Reference | Reference | Reference | ||||
| 1–6 | 0.81(0.37–1.78) | 0.594 | 1.82(0.67–4.96) | 0.240 | 1.15(0.61–2.16) | 0.663 | 0.41(0.11–1.49) | 0.177 |
| 0 | 1.34(0.59–3.02) | 0.481 | 2.37(0.84–6.70) | 0.104 | 1.76(0.91–3.38) | 0.093 | 0.56(0.41–2.24) | 0.415 |
OR: odds ratios; CI: Confidence Interval.
Presenting and Best-Corrected Acuity of Post-operative Eyes by Age, Gender, Education, Intraocular lens Status, and Year of Surgery.
| Variables | NO.(%)of Eyes | NO. (%) by Presenting Visual Acuity | NO. (%) of Best-Corrected Visual Acuity | |||||||
| ≥20/32 | 20/40–20/63 | <20/63–20/200 | <20/200 | ≥20/32 | 20/40–20/63 | <20/63–20/200 | <20/200 | |||
|
| ||||||||||
| 50–59 | 9 (7.0) | 5 (55.6) | 2 (22.2) | 1 (11.1) | 1 (11.1) | 8 (88.9) | 0 (0) | 0 (0) | 1 (11.1) | |
| 60–69 | 25 (19.4) | 8 (32.0) | 7 (28.0) | 5 (20.0) | 5 (20.0) | 16 (64.0) | 3 (12.0) | 1 (4.0) | 5 (20.0) | |
| 70–79 | 70 (54.3) | 16 (22.9) | 19 (27.1) | 15 (21.4) | 20 (28.6) | 28 (40.0) | 21 (30.0) | 8 (11.4) | 13 (18.6) | |
| 80+ | 25 (19.4) | 0 (0) | 5 (20.0) | 9 (36.0) | 11 (44.0) | 3 (12.0) | 6 (24.0) | 5 (20.0) | 11 (44.0) | |
|
| ||||||||||
| Male | 47 (36.4) | 13 (27.7) | 15 (31.9) | 10 (21.3) | 9 (19.1) | 24 (51.7) | 14 (29.8) | 2 (4.3) | 7 (14.9) | |
| Female | 82 (63.6) | 16 (19.5) | 18 (22.0) | 20(24.4) | 28 (34.1) | 31 (37.8) | 16 (19.5) | 12 (14.6) | 23 (28.0) | |
|
| ||||||||||
| 0 | 68 (52.7) | 11 (16.2) | 14 (20.6) | 18 (26.5) | 25 (36.8) | 21 (30.9) | 17 (25.0) | 11 (16.2) | 19 (27.9) | |
| 1–6 | 39 (30.2) | 6 (15.4) | 13 (33.3) | 11 (28.2) | 9 (23.1) | 17 (43.6) | 10 (25.6) | 3 (7.7) | 9 (23.1) | |
| >6 | 22 (17.1) | 12 (54.5) | 6 (27.3) | 1 (4.5) | 3 (13.6) | 17 (77.3) | 3 (13.6) | 0 (0) | 2 (9.1) | |
|
| ||||||||||
| Aphakic | 26 (20.2) | 1 (3.8) | 1 (3.8) | 5 (19.2) | 19 (73.1) | 1 (3.8) | 7 (26.9) | 4 (15.4) | 14 (53.8) | |
| Pseudophakic | 103 (79.8) | 28 (27.2) | 32 (31.1) | 25 (24.3) | 18 (17.5) | 54 (52.4) | 23 (22.3) | 10 (9.7) | 16 (15.5) | |
|
| ||||||||||
| ≥2001 | 93 (72.1) | 26 (28.0) | 28 (30.1) | 22 (23.7) | 17 (18.3) | 48 (51.6) | 22 (23.7) | 9 (9.7) | 14 (15.1) | |
| ≤2000 | 27 (20.9) | 3 (11.1) | 5 (18.5) | 6 (22.2) | 13(48.1) | 6 (22.2) | 8 (29.6) | 4 (14.8) | 9 (33.3) | |
| Missing | 9 (7.0) | 0 (0) | 0 (0) | 2 (22.2) | 7 (77.8) | 1 (11.1) | 0 (0) | 1 (11.1) | 7 (77.8) | |
|
| 129 (100) | 29 (22.5) | 33 (25.6) | 30 (23.3) | 37 (28.7) | 55 (42.6) | 30 (23.3) | 14 (10.9) | 30 (23.3) | |
IOL: intraocular lens.
Effect of Variables on Presenting and Best-Corrected Visual Acuity <20/63 in Post-operative Eyes by Multiple Logistic Regression Analysis.
| Variables | Presenting Visual Acuity | Best-Corrected Visual Acuity | ||||||
| P Value | Regression Coefficient | OR | 95% CI | P Value | Regression Coefficient | OR | 95% CI | |
|
| ||||||||
| 50–59 | Reference | Reference | ||||||
| 60–69 | 0.910 | 0.114 | 1.12 | 0.16–8.03 | 0.742 | 0.407 | 1.50 | 0.13–17.03 |
| 70–79 | 0.964 | −0.046 | 0.96 | 0.13–6.92 | 0.980 | 0.031 | 1.03 | 0.09–12.51 |
| 80+ | 0.298 | 1.147 | 3.15 | 0.36–27.36 | 0.329 | 1.267 | 3.55 | 0.28–45.29 |
|
| ||||||||
| Male | Reference | Reference | ||||||
| Female | 0.807 | 0.131 | 1.14 | 0.40–3.26 | 0.004 | 1.432 | 4.19 | 1.59–11.04 |
|
| ||||||||
| >6 | Reference | Reference | ||||||
| 1–6 | 0.014 | 1.870 | 6.49 | 1.46–28.89 | 0.494 | 0.658 | 1.93 | 0.29–12.73 |
| 0 | 0.001 | 2.320 | 10.18 | 2.43–42.61 | 0.204 | 1.263 | 3.54 | 0.50–24.81 |
|
| ||||||||
| Pseudophakia | Reference | Reference | ||||||
| Aphakia | <0.001 | 3.028 | 20.66 | 4.06–105.14 | <0.001 | 2.139 | 8.49 | 3.01–23.95 |
|
| ||||||||
| ≤2000 | Reference | Reference | ||||||
| ≥2001 | 0.577 | −0.352 | 0.70 | 0.20–2.42 | 0.547 | −0.374 | 0.69 | 0.20–2.33 |
OR: odds ratios; CI: Confidence Interval; IOL: intraocular lens.
Principal Cause of Presenting and Best-Corrected Visual Acuity <20/63 in Post-operative Eyes.
| Principal Cause | Presenting Visual Acuity | Best-Corrected Visual Acuity | ||
| Aphakia | Pseudophakia | Total | ||
| Refractive error/uncorrected aphakia | 5(20.8) | 17(39.5) | 22 (32.8) | 0 (0.0) |
| Retinal disorder | 7(29.1) | 5(11.6) | 12 (17.9) | 12(27.3) |
| AMD | 4(16.7) | 4(9.3) | 8 (11.9) | 8 (18.2) |
| Retinal detachment | 1(4.2) | 0(0.0) | 1 (1.5) | 1 (2.3) |
| Macular hole | 0(0.0) | 1(2.3) | 1 (1.5) | 1 (2.3) |
| Vitreous haze | 2(8.3) | 0(0.0) | 2 (3.0) | 2 (4.5) |
| Glaucoma | 2(8.3) | 8(18.6) | 10 (14.9) | 10 (22.7) |
| Optic atrophy | 6(25.0) | 2(4.7) | 8 (11.9) | 8 (18.2) |
| PCO | 1(4.2) | 4(9.3) | 5 (7.5) | 5 (11.4) |
| pterygium | 2(8.3) | 2(4.7) | 4(6.0) | 4 (9.0) |
| High myopic retinopathy | 1(4.2) | 2(4.7) | 3(4.5) | 2 (4.5) |
| Corneal opacity/scar | 0(0.0) | 1(2.3) | 1 (1.5) | 1 (2.3) |
| Other cause | 0(0.0) | 1(2.3) | 1 (1.5) | 1 (2.3) |
| Undetermined | 0(0.0) | 1(2.3) | 1 (1.5) | 1 (2.3) |
| All | 24(100) | 43(100) | 67 (100) | 44 (100) |
AMD: age-related macular degeneration; PCO: posterior capsule opacification.
Data are presented as No. (%) of eyes.